PRKAA2 and pancreatic neoplasm: To substantiate the operation of AMPK-mediated inhibition of mitogenic signaling in pancreatic cancer cells, we determined whether treatment with A-769662, a direct AMPK agonist [78], [79], inhibits mTORC1 and DNA synthesis in PANC-1 cells.